Table 4.
Variables | SE value | Hazard ratio | Risk ratio (95 % CI) | P value |
---|---|---|---|---|
Age (≥5 y) | 1.043 | 0.835 | 0.108–6.451 | 0.863 |
Gender (female) | 0.558 | 0.806 | 0.270–2.409 | 0.700 |
Tumor enucleated location (left) | 0.536 | 0.702 | 0.246–2.006 | 0.702 |
Primary tumor (cT3 + T4) | 0.680 | 0.122 | 0.032–0.462 | 0.002* |
Regional lymph node (cN1 + N2) | 0.793 | 0.135 | 0.028–0.638 | 0.012* |
cTNM stage (III + IV) | 1.043 | 0.098 | 0.013–0.760 | 0.026* |
Largest tumor base (>15 mm) | 0.591 | 0.297 | 0.093–0.948 | 0.040* |
Tumor thickness (>10 mm) | 0.545 | 0.668 | 0.230–1.943 | 0.459 |
Differentiation (poorly) | 0.789 | 0.085 | 0.018–0.401 | 0.002* |
TAZ high expression | 0.601 | 0.314 | 0.112–1.129 | 0.042* |
*P < 0.05